Machine learning-based decision support model for selecting intra-arterial therapies for unresectable hepatocellular carcinoma: A national real-world evidence-based study-Reference-Cited by-同舟云学术

Machine learning-based decision support model for selecting intra-arterial therapies for unresectable hepatocellular carcinoma: A national real-world evidence-based study

Published:2024-07-06 Issue:5 Volume:131 Page:832-842
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

An Chao,Wei Ran,Liu Wendao,Fu Yan,Gong Xiaolong,Li Chengzhi,Yao Wang,Zuo Mengxuan,Li Wang,Li Yansheng,Wu Fatian,Liu Kejia,Yan Dong^ORCID,Wu Peihong^ORCID,Han Jianjun

Publisher

Springer Science and Business Media LLC

Link

https://www.nature.com/articles/s41416-024-02784-7.pdf

Reference34 articles.

1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram L, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209–49. https://doi.org/10.3322/caac.21660.

2. Marrero JA, Kulik LM, Sirlin CB, Zhu AX, Finn RS, Abecassis MM, et al. Diagnosis, staging, and management of hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases. Hepatology. 2018;68:723–50. https://doi.org/10.1002/hep.29913.

3. Villanueva A. Hepatocellular Carcinoma. N. Engl J Med. 2019;380:1450–62. https://doi.org/10.1056/NEJMra1713263.

4. Park JW, Chen M, Colombo M, Roberts LR, Schwartz M, Chen PJ, et al. Global patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE Study. Liver Int. 2015;35:2155–66. https://doi.org/10.1111/liv.12818.

5. Ghanaati H, Mohammadifard M, Mohammadifard M. A review of applying transarterial chemoembolization (TACE) method for management of hepatocellular carcinoma. J Fam Med Prim Care. 2021;10:3553–60. https://doi.org/10.4103/jfmpc.jfmpc_2347_20.